Aayush Wellness Ltd
Incorporated in 1984, Aayush Wellness Ltd provides nutraceutical, personalized health
care, preventive wellness, and digital health solutions[1]
- Market Cap ₹ 137 Cr.
- Current Price ₹ 28.2
- High / Low ₹ 267 / 26.9
- Stock P/E 34.2
- Book Value ₹ 2.53
- Dividend Yield 0.09 %
- ROCE 36.1 %
- ROE 39.1 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.9%
- Company's working capital requirements have reduced from 94.1 days to 11.1 days
Cons
- Stock is trading at 11.2 times its book value
- Tax rate seems low
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.2.61 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 5 | 100 | 188 | 132 | 127 | 152 | 17 | 8 | 1 | 73 | 155 | |
| 0 | 5 | 100 | 187 | 132 | 126 | 150 | 19 | 9 | 0 | 70 | 154 | |
| Operating Profit | -0 | -0 | 0 | 1 | -0 | 2 | 2 | -2 | -1 | 0 | 3 | 2 |
| OPM % | -29% | -4% | 0% | 0% | -0% | 1% | 1% | -11% | -10% | 58% | 5% | 1% |
| 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0 | 0 | 0 | 1 | 1 | 1 | 1 | -2 | -0 | 1 | 3 | 4 |
| Tax % | -50% | 0% | 36% | 25% | 25% | 26% | 27% | -1% | 0% | 3% | 0% | 10% |
| -0 | 0 | 0 | 1 | 1 | 1 | 0 | -2 | -0 | 1 | 3 | 4 | |
| EPS in Rs | -0.00 | 0.02 | 0.07 | 0.14 | 0.12 | 0.13 | 0.09 | -0.42 | -0.07 | 0.12 | 0.69 | 0.83 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 1% |
| 3 Years: | 168% |
| TTM: | 112% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 57% |
| 3 Years: | 128% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 68% |
| 3 Years: | 140% |
| 1 Year: | -82% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | 37% |
| Last Year: | 39% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 5 |
| Reserves | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 2 | 1 | 2 | 3 | 7 |
| 0 | 0 | 1 | 0 | 1 | 12 | 2 | 5 | 0 | 0 | 0 | 4 | |
| -0 | 1 | 11 | 37 | 29 | 29 | 27 | 1 | 0 | 0 | 0 | 0 | |
| Total Liabilities | 4 | 6 | 16 | 43 | 35 | 46 | 36 | 11 | 4 | 5 | 9 | 17 |
| 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 4 | 5 | 16 | 42 | 34 | 46 | 36 | 11 | 4 | 5 | 9 | 16 | |
| Total Assets | 4 | 6 | 16 | 43 | 35 | 46 | 36 | 11 | 4 | 5 | 9 | 17 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4 | -0 | -1 | 6 | -3 | -10 | 6 | -3 | 5 | -1 | 0 | -5 | |
| 0 | 0 | 0 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | 2 | |
| 4 | 0 | 1 | -1 | 1 | 11 | -9 | 3 | -5 | 0 | 0 | 4 | |
| Net Cash Flow | 0 | -0 | 0 | 4 | -2 | 1 | -3 | 0 | -0 | -1 | 0 | 0 |
| Free Cash Flow | -4 | -0 | -1 | 5 | -3 | -10 | 6 | -2 | 5 | -1 | 0 | -5 |
| CFO/OP | 18,150% | 42% | -465% | 738% | 3,100% | -528% | 321% | 140% | -573% | -160% | 11% | -266% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 361 | 50 | 36 | 65 | 10 | 58 | 61 | 59 | 12 | 1 | 0 |
| Inventory Days | 0 | 0 | 7 | 37 | 23 | 120 | 25 | 136 | 0 | 1 | 2 | |
| Days Payable | 45 | 78 | 83 | 89 | 72 | 17 | 1 | 1 | ||||
| Cash Conversion Cycle | 0 | 361 | 11 | -6 | 5 | 40 | 11 | 180 | 59 | 12 | 1 | 1 |
| Working Capital Days | 19,293 | 277 | 17 | -1 | 9 | 40 | 19 | 181 | 96 | 268 | 3 | 11 |
| ROCE % | -1% | 2% | 12% | 23% | 20% | 15% | 14% | -15% | -5% | 13% | 51% | 36% |
Insights
In beta| Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations (Agri-Commodity & Wellness) INR Lakhs |
|
|||||||||
| Trade Receivable Turnover Ratio x |
||||||||||
| Employee Count Number |
||||||||||
| Foreign Exchange Earnings USD |
||||||||||
| Number of Diagnostic Tests (Health ATM) Number |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Submission of Newspaper Advertisement of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
29 May - Aayush Wellness reported FY26 revenue of ₹15,548.20 lakh, up 112%, with Q4 revenue at ₹4,840.70 lakh.
-
Board Meeting Outcome for Outcome Of Board Meeting For Audited Standalone & Consolidated Financial Results Of The Company
29 May - Board approved FY26 audited results; revenue rose 112% to ₹15,548 lakhs, net profit ₹398 lakhs.
-
Results For The Quarter And Financial Year Ended March 31 2026
29 May - Board approved FY26 audited results; revenue rose 112% to Rs15,548 lakhs, profit Rs398 lakhs.
-
Board Meeting Intimation for Approval Of Audited Standalone & Consolidated Financial Results
22 May - Board meets May 29, 2026 to approve audited FY26 standalone and consolidated results.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
AWL provides comprehensive healthcare solutions and nutritional support. It has an integrated platform where individuals can access a wide range of health and wellness solutions tailored to their unique needs through AWL's Online Doctor Consultations, Nutritional Support Programs and Health Awareness Campaigns